☆ 4.4 Article

KORTUC, a novel hydrogen peroxide-based radiosensitizer for the enhancement of brachytherapy in patients with unresectable recurrent uterine cervical cancer

ONCOLOGY LETTERS (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

Actual practice of Kochi oxydol radiation therapy for unresectable carcinomas by intra-tumoral administration of hydrogen peroxide as a radiosensitizer

Shiro Obata et al.

Summary: KORTUC is a novel cancer treatment method developed in Japan that targets resistance factors in cancer therapy to enhance the effects of conventional treatments. The study shows that KORTUC has shown good efficacy and tolerable safety for various types of radioresistant tumors.

MOLECULAR AND CLINICAL ONCOLOGY (2022)

Add to Collection

Review Oncology

Combined modality including novel sensitizers in gynecological cancers

Yuedan Zhou et al.

Summary: The standard treatment for locally advanced gynecological cancers is platinum-based concurrent chemoradiotherapy, but current chemotherapeutic drugs are only transiently effective and patients often develop resistance and distant metastases. This review discusses novel therapies that could work synergistically with conventional chemoradiotherapy, including anti-angiogenic agents, immunotherapy, tumor-infiltrating lymphocytes therapy, and apoptosis inducers. Radiosensitizers such as nanoparticles are also being tested to maximize the effect of radiotherapy locally.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2022)

Add to Collection

Review Oncology

Combined modality management of advanced cervical cancer including novel sensitizers

Michelle Tseng et al.

Summary: The management of advanced cervical cancer has evolved over time, with combined modality treatment involving surgery, radiotherapy, and systemic therapy showing improved outcomes. This article reviews recent advances and international guidelines in the management of cervical cancer.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2022)

Add to Collection

Article Oncology

New enzyme-targeting radiosensitizer (KORTUC II) treatment for locally advanced or recurrent breast cancer

Taiju Shimbo et al.

Summary: KORTUC II, a widely used radiosensitizer in Japan, has shown effective treatment for locally advanced breast cancer and recurrent breast cancer, achieving high rates of local tumor control. It is expected to be an inexpensive and promising radiotherapy method due to its safety and excellent radio-sensitizing effect.

MOLECULAR AND CLINICAL ONCOLOGY (2021)

Add to Collection

Article Oncology

Intratumoral Hydrogen Peroxide With Radiation Therapy in Locally Advanced Breast Cancer: Results From a Phase 1 Clinical Trial

Samantha Nimalasena et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)

Add to Collection

Article Oncology

High-dose-rate interstitial brachytherapy with hypoxic radiosensitizer KORTUC II for unresectable pelvic sidewall recurrence of uterine cervical cancer: a case report

Mio Nakata et al.

JOURNAL OF CONTEMPORARY BRACHYTHERAPY (2020)

Add to Collection

Article Oncology

Biological effects of hydrogen peroxide administered intratumorally with or without irradiation in murine tumors

Taiki Takaoka et al.

CANCER SCIENCE (2017)

Add to Collection

Article Oncology

Preliminary results of MRI-assisted high-dose-rate interstitial brachytherapy for uterine cervical cancer

Ken Yoshida et al.

BRACHYTHERAPY (2015)

Add to Collection

Article Oncology

Non-Surgical Breast-Conserving Treatment (KORTUC-BCT) Using a New Radiosensitization Method (KORTUC II) for Patients with Stage I or II Breast Cancer

Yasuhiro Ogawa et al.

CANCERS (2015)

Add to Collection

Article Oncology

Reirradiation Using High-Dose-Rate Interstitial Brachytherapy for Locally Recurrent Cervical Cancer A Single Institutional Experience

Seiji Mabuchi et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2014)

Add to Collection

Article Oncology

Safety and efficacy of image-guided enzyme-targeting radiosensitization and intraoperative radiotherapy for locally advanced unresectable pancreatic cancer

Akihito Nishioka et al.

ONCOLOGY LETTERS (2014)

Add to Collection

Article Oncology

Three-dimensional image-based high-dose-rate interstitial brachytherapy for vaginal cancer

Sushi Beriwal et al.

BRACHYTHERAPY (2012)

Add to Collection

Article Oncology

Comparison of predicted and clinical response to radiotherapy: A radiobiology modelling study

Mattias Hedman et al.

ACTA ONCOLOGICA (2009)

Add to Collection

Article Oncology

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. A. Eisenhauer et al.

EUROPEAN JOURNAL OF CANCER (2009)

Add to Collection

Article Oncology

Phase I study of a new radiosensitizer containing hydrogen peroxide and sodium hyaluronate for topical tumor injection: A new enzyme-targeting radiosensitization treatment, Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas, Type II (KORTUC II)

Yasuhiro Ogawa et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2009)

Add to Collection

Article Oncology

Magnetic resonance-guided interstitial therapy for vaginal recurrence of endometrial cancer

Akila N. Viswanathan et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)

Add to Collection

Review Oncology

HIF-I and tumour radiosensitivity

B. J. Moeller et al.

BRITISH JOURNAL OF CANCER (2006)

Add to Collection

Article Oncology

Interstitial brachytherapy for salvage treatment of vaginal recurrences in previously unirradiated endometrial cancer patients

S Nag et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)

Add to Collection

Article Oncology

Open magnetic resonance imaging using titanium-zirconium needles: Improved accuracy for interstitial brachytherapy implants?

Y Popowski et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.